News | July 10, 2009

CMS Stats Show One in Five Medicare Patients Readmitted Within a Month

July 10, 2009 – New information added this week to the Centers for Medicare and Medicaid Services’ (CMS) Hospital Compare Web site shows patients frequently return to a hospital after discharge, a possible indicator of how well the facility did the first time around.

On average, one in five Medicare beneficiaries discharged from a hospital today will return within a month. Reducing the rate of hospital readmissions to improve quality and achieve savings are key components of President Obama’s healthcare reform agenda.

"The President and Congress have both identified the reduction of readmissions as a target area for health reform," said U.S. Health and Human Services (HHS) Secretary Kathleen Sebelius. "When we reduce readmissions, we improve the quality of care patients receive and cut healthcare costs."

With the update announced today, Hospital Compare will provide better data on the previously posted mortality rates for individual hospitals, as well as the new data on 30-day readmissions for heart attack, heart failure and pneumonia. Previously, Hospital Compare had provided only mortality rates for these three conditions.

Research shows that hospital readmissions reduce the quality of health care while increasing hospital costs. Hospital Compare data show that 19.9 percent of patients admitted for heart attack treatment will return to the hospital within 30 days, and 24.5 percent admitted for heart failure will return within 30 days.

“The American College of Cardiology (ACC) supports public reporting of these measures because they are intended to drive quality improvement efforts to enhance care in these important and high volume clinical areas,” said Alfred Bove, M.D., ACC president. “Reporting of the readmission measures provides hospitals with critical information about the quality of care they provide. As Congress gets set to vote on overarching health reform bills in the coming weeks, these data are critical to helping benchmark and ensure quality care.”

The ACC is encouraging its members to review and act on the data. It is also gearing up to help hospitals respond to the measures by guiding efforts to improve patient care and by providing leadership and technical assistance. The ACC's new Hospital to Home (H2H) initiative will provide evidence-based strategies for reducing cardiovascular readmissions by 20 percent by 2012. This comprehensive new effort, which is in partnership with the Institute for Healthcare Improvement (IHI), is designed to improve the transition from hospital to home and improve outcomes of cardiovascular health.

For more information: www.hospitalcompare.hhs.gov, www.cms.hhs.gov, www.acc.org

Related Content

Videos | Cath Lab| January 04, 2018
Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif.,
FDA Initiates Class I Recall of Sterilmed Reprocessed Agilis Steerable Introducer Sheath
News | Cath Lab| January 04, 2018
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Sterilmed’s Agilis Steerable Introducer...
The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA atherectomy system. Athar Ansari, M.D.

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA system. 

Feature | Cath Lab| November 24, 2017 | Athar Ansari, M.D., FACC
As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings acros
Videos | Cath Lab| November 08, 2017
Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on
Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab| November 06, 2017
November 6, 2017 – Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found
Culprit Lesion-Only PCI Improves Outcomes for Cardiogenic Shock Patients Compared to Multivessel PCI
News | Cath Lab| November 01, 2017
November 1, 2017 — Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found an initial strateg
Three-Year Quality of Life Improvements Similar for PCI and CABG in Left Main Disease
News | Cath Lab| October 30, 2017
October 30, 2017 — New study results from the EXCEL trial comparing the quality of life (QoL) of patients with left m
Corindus Evaluates Incorporating HeartFlow Technology With CorPath GRX System
Technology | Cath Lab| October 26, 2017
Corindus Vascular Robotics Inc. announced that it will incorporate the HeartFlow FFRct (fractional flow reserve-...
Shockwave Medical Announces $35 Million in New Financing
News | Cath Lab| October 24, 2017
October 24, 2017 — Shockwave Medical reported $35 million in new financing, an extension of the company’s previously
Overlay Init